Literature DB >> 31478323

Changing trends in surgical management of renal tumours from 2000 to 2016: a nationwide study of Medicare claims data.

Stephen Ali1,2, Thomas Ahn3,4, Nathan Papa5, Marlon Perera3,5, Patrick Teloken3, Geoffrey Coughlin6, Simon T Wood3,7, Matthew J Roberts3,4,8.   

Abstract

BACKGROUND: Guidelines recommend nephron sparing surgery where possible for patients with T1 renal tumours. The trends of nephron sparing surgery outside the USA are limited, particularly since the introduction of robotic-assisted partial nephrectomy (RAPN). The aim of this study was to describe contemporary surgical management patterns of renal tumours in Australia according to Medicare claims data.
METHODS: Claims data according to the Medicare Benefits Schedule on surgical management of renal tumours in adult Australians between January 2000 and December 2016 was collated. Analysis of absolute number, population-adjusted rate and renal cancer-adjusted rate of interventions according to age and gender were performed, as well as proportion of RAPN.
RESULTS: Between 2000 and 2016, the rate of partial nephrectomy (PN) increased while radical nephrectomy (RN) remained stable (PN: 0.87-4.16, RN: 6.52-6.70 per 100 000 population). Since 2015, PN has become more common than RN in patients aged 25 to 44 years (0.98 versus 0.95 procedures per 100 000 population). Renal cancer-adjusted rate exhibited a trend towards increasing utilization of PN and reduced RN across all age groups. An increase in overall surgical treatment was observed (25%-41%), mainly due to increased treatment of patients older than 75 years. The proportion of RAPN was seen to rapidly increase (4.7% in 2010 to 58% in 2016).
CONCLUSIONS: Treatment utilization for renal masses has markedly changed in Australia according to Medicare claims. PN is increasingly replacing RN in younger patients, and older patients are receiving more surgical treatment. The impact of increased RAPN utilization is yet to be determined.
© 2019 Royal Australasian College of Surgeons.

Entities:  

Keywords:  laparoscopic nephrectomy; nephrectomy; partial nephrectomy; radical nephrectomy; renal cell carcinoma

Mesh:

Year:  2019        PMID: 31478323     DOI: 10.1111/ans.15385

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  5 in total

1.  Variability in surgical management of kidney cancer between urban and rural hospitals in Queensland, Australia: a population-based analysis.

Authors:  Megan K Forbes; Evan P Owens; Simon T Wood; Glenda C Gobe; Robert J Ellis
Journal:  Transl Androl Urol       Date:  2020-06

2.  What a mesh! An Australian experience using national female continence surgery trends over 20 years.

Authors:  Aoife McVey; Liang G Qu; Garson Chan; Marlon Perera; Janelle Brennan; Eric Chung; Johan Gani
Journal:  World J Urol       Date:  2021-04-09       Impact factor: 4.226

3.  The R.E.N.A.L score's relevance in determining perioperative and oncological outcomes: a Middle-Eastern tertiary care center experience.

Authors:  Nassib Abou Heidar; Nizar Hakam; Jose M El-Asmar; Jad Najdi; Mark A Khauli; Jad Degheili; Albert El-Hajj; Rami Nasr; Wassim Wazzan; Muhammad Bulbul; Deborah Mukherji; Raja Khauli
Journal:  Arab J Urol       Date:  2022-04-17

4.  Rapid Segmentation of Renal Tumours to Calculate Volume Using 3D Interpolation.

Authors:  Michael Y Chen; Maria A Woodruff; Boon Kua; Nicholas J Rukin
Journal:  J Digit Imaging       Date:  2021-02-09       Impact factor: 4.056

5.  Transperitoneal vs retroperitoneal minimally invasive partial nephrectomy: comparison of perioperative outcomes and functional follow-up in a large multi-institutional cohort (The RECORD 2 Project).

Authors:  Francesco Porpiglia; Andrea Mari; Daniele Amparore; Cristian Fiori; Alessandro Antonelli; Walter Artibani; Pierluigi Bove; Eugenio Brunocilla; Umberto Capitanio; Luigi Da Pozzo; Fabrizio Di Maida; Paolo Gontero; Nicola Longo; Giancarlo Marra; Bernardo Rocco; Riccardo Schiavina; Claudio Simeone; Salvatore Siracusano; Riccardo Tellini; Carlo Terrone; Donata Villari; Vincenzo Ficarra; Marco Carini; Andrea Minervini
Journal:  Surg Endosc       Date:  2020-08-27       Impact factor: 4.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.